Okada Satoshi, Weatherhead Elizabeth, Targoff Ira N, Wesley Robert, Miller Frederick W
Center for Biologics Evaluation and Research, Food and Drug Administration/NIH, Bethesda, MD, USA.
Arthritis Rheum. 2003 Aug;48(8):2285-93. doi: 10.1002/art.11090.
To determine if geoclimatic factors may influence the nature and frequency of dermatomyositis (DM), polymyositis, and associated autoantibodies around the world.
We assessed, in the first global evaluation of these conditions, the relationship between 13 geoclimatic variables that may modulate disease and the relative proportion of DM and its associated autoantibody anti-Mi-2, directed against an SNF2-superfamily helicase associated with the nucleosome remodeling and histone acetylation and deacetylation complex, in a global myositis population. Altogether, 919 consecutive patients from populations at 15 locations were studied.
Univariate and multivariate analyses demonstrated that of the variables evaluated, surface ultraviolet (UV) radiation intensity (irradiance) most strongly contributed to the relative proportion of DM and was strongly related to the proportion of anti-Mi-2 autoantibodies (weighted r = 0.939, P < 4 x 10(-7) and weighted r = 0.69, P = 0.02, respectively). Published ethnogeographic immunogenetic allele frequencies imply that the striking differences in the proportion of DM- and DM-specific autoantibodies observed around the world are not the result of inherent global variations in known genetic risk factors.
These data suggest that UV radiation exposure may modulate the clinical and immunologic expression of an autoimmune disease in different populations around the world.
确定地理气候因素是否会影响全球范围内皮肌炎(DM)、多发性肌炎及其相关自身抗体的性质和频率。
在对这些病症的首次全球评估中,我们评估了13个可能调节疾病的地理气候变量与全球肌炎患者群体中DM及其相关自身抗体抗Mi-2(针对与核小体重塑及组蛋白乙酰化和去乙酰化复合物相关的SNF2超家族解旋酶)的相对比例之间的关系。共研究了来自15个地点的919例连续患者。
单因素和多因素分析表明,在所评估的变量中,地表紫外线(UV)辐射强度(辐照度)对DM的相对比例影响最大,且与抗Mi-2自身抗体的比例密切相关(加权r分别为0.939,P < 4×10⁻⁷和0.69,P = 0.02)。已发表的种族地理免疫遗传等位基因频率表明,全球观察到的DM及其特异性自身抗体比例的显著差异并非已知遗传风险因素固有全球变异的结果。
这些数据表明,紫外线辐射暴露可能会调节世界各地不同人群自身免疫性疾病的临床和免疫表现。